Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Epstein-Barr-negative MS: a true phenomenon?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Epigenetic modulation of AREL1 and increased HLA expression in brains of multiple system atrophy patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic analysis of Charcot-Marie-Tooth disease in Denmark and the implementation of a next generation sequencing platform

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Peripheral immune cell changes correlate to disease progression in Multiple System Atrophy and Parkinson’s disease

    Research output: Contribution to conferencePosterResearchpeer-review

  5. Peripheral neuropathy in hereditary spastic paraplegia caused by REEP1 variants

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: We hypothesize alterations in the quality and quantity of anti-43-kDa TAR DNA-binding protein (TDP-43) naturally occurring autoantibodies (NAbs) in patients with amyotrophic lateral sclerosis (ALS); therefore, we assessed relative binding properties of anti-TDP-43 NAbs composite in plasma from patients with ALS in comparison with healthy individuals.

METHODS: ELISA competition assay was used to explore the apparent avidity/affinity of anti-TDP-43 NAbs in plasma from 51 normal controls and 30 patients with ALS. Furthermore, the relative levels of anti-TDP-43 NAbs within the immunoglobulin (Ig) classes of IgG (isotype IgG1-4) and IgMs were measured using classical indirect ELISA. The occurring results were hereafter correlated with the measures of disease duration and disease progression.

RESULTS: High-avidity/affinity anti-TDP-43 NAbs levels were significantly reduced in plasma samples from patients with ALS. In addition, a significant decrease in relative levels of anti-TDP-43 IgG3 and IgM NAbs and a significant increase in anti-TDP-43 IgG4 NAbs were observed in ALS plasma vs controls. Furthermore, a decrease in global IgM and an increase in IgG4 levels were observed in ALS. These aberrations of humoral immunity correlated with disease duration, but did not correlate with ALS Functional Rating Scale-Revised scores.

CONCLUSIONS: Our results may suggest TDP-43-specific immune aberrations in patients with ALS. The skewed immune profiles observed in patients with ALS could indicate a deficiency in the clearance capacity and/or blocking of TDP-43 transmission and propagation. The decrease in levels of high affinity/avidity anti-TDP-43 NAbs and IgMs correlates with disease progression and may be disease predictors.

Original languageEnglish
JournalNeurology: Neuroimmunology and NeuroInflammation
Volume8
Issue number2
ISSN2332-7812
DOIs
Publication statusPublished - Mar 2021

ID: 61628093